Chercheur

    Michel Duval , M.D.

    michel.duval@umontreal.ca
    Michel Duval
    Axe de recherche
    Maladies virales, immunitaires et cancers
    Thème de recherche
    Transplantation de cellules souches hématopoïétiques et immunothérapies
    Adresse
    CHUSJ

    Téléphone
    514 345-4931 #6746

    Fax
    514 345-4792

    Titres

    • Professeur titulaire de clinique, Département de pédiatrie, Université de Montréal
    • Chef du Service d’hématologie-oncologie, CHU Sainte-Justine

    Stage(s) proposé(s)

    Aucune offre

    Sommaire de carrière

    Après une formation à Paris, France (Universités Pierre-et-Marie-Curie et Université Diderot) en pédiatrie et en immunologie, il débuta sa carrière dans le service d’Hémato-Immunologie et de Greffe de Moelle de l’Hôpital Robert-Debré à Paris. En 2001, il rejoint l’équipe d’hématologie-oncologie du CHU Sainte-Justine, et particulièrement le programme de greffe hématopoïétique. Il a créé et coordonne le Groupe de recherche en transplantation et greffe de sang de cordon du CHU Sainte-Justine.

    Ses intérêts de recherche sont l’immunologie du sang de cordon et de la greffe de sang de cordon, ainsi que les soins palliatifs, la douleur et l’éthique de la communication. Il est l’auteur de plus de 40 articles scientifiques. Ses recherches sont financées par le FRSQ et la Fondation Centre de cancérologie Charles-Bruneau.

Publications

Implication of different effector mechanisms by cord blood-derived and peripheral blood-derived cytokine-induced killer cells to kill precursor B acute lymphoblastic leukemia cell lines - Durrieu L, Lemieux W, Dieng Mame M, Fontaine F, Duval M, Le Deist F, Haddad E. Implication of different effector mechanisms by cord blood-derived and peripheral blood-derived cytokine-induced killer cells to kill precursor B acute lymphoblastic leukemia cell lines. Cytotherapy 2014; 16(6): 845-856.

Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematopoietic stem cell transplantation - Ansari M, Théorêt Y, Rezgui MA, Peters C, Mezziani S, Desjean C, Vachon MF, Champagne M, Duval M, Krajinovic M, Bittencourt H, Pediatric Disease Working Parties of the European Blood and Marrow Transplant Group. Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematopoietic stem cell transplantation. Therap Drug Monit 2014; 36(1): 93-99.

Risk of cytomegalovirus infection and disease after umbilical cord blood transplantation in children - Crisinel PA, Duval M, Crisinel DT, Mallette B, Bellier N, Vachon MF, Dedeken L, Rousseau C, Tapiero B, Ovetchkine P. Risk of cytomegalovirus infection and disease after umbilical cord blood transplantation in children. Can J Infect Dis Med Microbiol 2013; 24(1): e11-15.

Excess of veno-occlusive disease in a randomized clinical trial on a higher trigger for red blood cell transfusion after bone marrow transplantation: a Canadian Blood and Marrow Transplant Group Trial - Robitaille N, Lacroix J, Alexandrov L, Clayton L, Cortier M, Schultz KR, Bittencourt H, Duval M. Excess of veno-occlusive disease in a randomized clinical trial on a higher trigger for red blood cell transfusion after bone marrow transplantation: a Canadian Blood and Marrow Transplant Group Trial. Biol Blood Marrow Tr 2013; 19(3): 468-473.

Rising serum thyroxine levels and chorea in graves' disease - Leblicq C, Duval M, Carmant L, Van Vliet G, Alos N. Rising serum thyroxine levels and chorea in graves' disease. Pediatrics 2013; 131(2): e616-619.

Reconstitution of maturating and regulatory lymphocyte subsets after cord blood and BMT in children - Charrier E, Cordeiro P, Brito RM, Mezziani S, Herblot S, Le Deist F, Duval M. Reconstitution of maturating and regulatory lymphocyte subsets after cord blood and BMT in children. Bone Marrow Transplant 2013; 48(3): 376-382.

The clinical relevance of pre-formed anti-HLA and anti-MICA antibodies after cord blood transplantation in children - Ansari M, Uppugunduri CR, Ferrari-Lacraz S, Bittencourt H, Gumy-Pause F, Chalandon Y, Tiercy JM, Schechter T, Gassas A, Doyle J, Dupuis L, Duval M, Krajinovic M, Villard J. The clinical relevance of pre-formed anti-HLA and anti-MICA antibodies after cord blood transplantation in children. PLoS ONE 2013; 8(8): e72141.

Post-transcriptional down-regulation of Toll-like receptor signaling pathway in umbilical cord blood plasmacytoid dendritic cells - Charrier E, Cordeiro P, Cordeau M, Dardari R, Michaud A, Harnois M, Merindol N, Herblot S, Duval M. Post-transcriptional down-regulation of Toll-like receptor signaling pathway in umbilical cord blood plasmacytoid dendritic cells. Cell Immunol 2012; 276(1-2): 114-121.

Defects in CD54 and CD86 up-regulation by plasmacytoid dendritic cells during pregnancy - Cordeau M, Herblot S, Charrier E, Audibert F, Cordeiro P, Harnois M, Duval M. Defects in CD54 and CD86 up-regulation by plasmacytoid dendritic cells during pregnancy. Immunol Invest 2012; 41(5): 497-506.

Genotype analysis of tumor-initiating cells expressing CD133 in neuroblastoma - Cournoyer S, Nyalendo C, Addioui A, Belounis A, Beaunoyer M, Aumont A, Teira P, Duval M, Fernandes K, Fetni R, Haddad E, Sartelet H. Genotype analysis of tumor-initiating cells expressing CD133 in neuroblastoma. Gene Chromosomes Cancer 2012; 51(8): 792-804.

Transfusion-related Epstein-Barr virus infection among stem cell transplant recipients: a retrospective cohort study in children - Trottier H, Buteau C, Robitaille N, Duval M, Tucci M, Lacroix J, Alfieri C. Transfusion-related Epstein-Barr virus infection among stem cell transplant recipients: a retrospective cohort study in children. Transfusion 2012; 52(12): 2653-2663.

Reconstitution of protective immune responses against cytomegalovirus and varicella zoster virus does not require disease development in pediatric recipients of umbilical cord blood transplantation - Merindol N, Salem Fourati I, Brito RM, Grenier A, Charrier E, Cordeiro P, Caty M, Mezziani S, Malette B, Duval M, Alfieri C, Ovetchkine P, Le Deist F, Soudeyns H. Reconstitution of protective immune responses against cytomegalovirus and varicella zoster virus does not require disease development in pediatric recipients of umbilical cord blood transplantation. J Immunol 2012; 189(10): 5016-5028.

Secondary pulmonary alveolar proteinosis after unrelated cord blood hematopoietic cell transplantation - Ansari M, Rougemont A-L, Le Deist F, Ozsahin H, Duval M, Champagne M, Fournet JC. Secondary pulmonary alveolar proteinosis after unrelated cord blood hematopoietic cell transplantation. Pediatr Transplant 2012; 16(5): E146–E149.

CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway - Sartelet H, Imbriglio T, Nyalendo C, Haddad E, Annabi B, Duval M, Fetni R, Victor K, Alexandrov L, Sinnett D, Fabre M, Vassal G. CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway. Histopathology 2012; 60(7): 1144-1155.

Pharmacokinetic profile of valganciclovir in pediatric transplant recipients - Launay E, Théorêt Y, Litalien C, Duval M, Alvarez F, Lapeyraque AL, Phan V, Larocque D, Poirier N, Lamarre V, Ovetchkine P. Pharmacokinetic profile of valganciclovir in pediatric transplant recipients. Pediatr Infect Dis J 2012; 31(4): 405-407.

Engraftment of unrelated cord blood after reduced-intensity conditioning regimen in children with refractory neuroblastoma: a feasibility trial - Jubert C, Wall DA, Grimley M, Champagne MA, Duval M. Engraftment of unrelated cord blood after reduced-intensity conditioning regimen in children with refractory neuroblastoma: a feasibility trial. Bone Marrow Transplant 2011; 46(2): 232-237.

Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia - Bizzetto R, Bonfim C, Rocha V, Socie G, Locatelli F, Chan K, Ramirez O, Stein J, Nabhan S, Miranda E, Passweg J, de Souza CA, Gluckman E, Duval M, Eurocord-Netcord and EBMT. Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia. Haematologica 2011; 96(1): 134-141.

Novel associations between activating killer-cell immunoglobulin-like receptor genes and childhood leukemia - Almalte Z, Samarani S, Iannello A, Debbeche O, Duval M, Infante-Rivard C, Amre D, Sinnett D, Ahmad A. Novel associations between activating killer-cell immunoglobulin-like receptor genes and childhood leukemia. Blood 2011; 118(5): 1323-1328.

Complementary and contrasting roles of NK cells and T cells in pediatric umbilical cord blood transplantation - Merindol N, Charrier E, Duval M, Soudeyns H. Complementary and contrasting roles of NK cells and T cells in pediatric umbilical cord blood transplantation. J Leukoc Biol 2011; 90(1): 49-60.

CD8+ T-cell reconstitution in recipients of umbilical cord blood transplantation and characteristics associated with leukemic relapse - Merindol N, Champagne MA, Duval M, Soudeyns H. CD8+ T-cell reconstitution in recipients of umbilical cord blood transplantation and characteristics associated with leukemic relapse. Blood 2011; 118(16): 4480-4488.

Activation of the phosphatidylinositol 3'-kinase/AKT pathway in neuroblastoma and its regulation by thioredoxin 1 - Sartelet H, Rougemont A-L, Fabre M, Castaign M, Duval M, Fetni R, Michiels S, Beaunoyer M, Vassal G. Activation of the phosphatidylinositol 3'-kinase/AKT pathway in neuroblastoma and its regulation by thioredoxin 1. Hum Pathol 2011; 42(11): 1727-1739.

Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission - Nemecek ER, Ellis K, He W, Bunin NJ, Bajwa RS, Cheerva A, Cairo M, Dvorak C, Duval M, Davies S, Eapen M, Gross TG, Hussein AA, MacMillan ML, Mehta PA, Pulsipher M, Seber A, Woolfrey AE, Frangoul H, Carpenter PA. Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission. Biol Blood Marrow Tr 2011; 17(12): 1833-1840.

Low systemic ganciclovir exposure and preemptive treatment failure of cytomegalovirus reactivation in a transplanted child - Autmizguine J, Théorêt Y, Launay E, Duval M, Rousseau C, Tapiero B, Boivin G, Ovetchkine P. Low systemic ganciclovir exposure and preemptive treatment failure of cytomegalovirus reactivation in a transplanted child. J Popul Ther Clin Pharmacol 2011; 18(2): e257-260.

Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure - Duval M, Klein J, He W, Cahn JY, Cairns P, Camitta BM, Kamble R, Copelan E, de Lima M, Gupta V, Keating A, Lazarus HM, Litzow MR, Marks DI, Maziarz RT, Rizzieri DA, Schiller G, Schultz KR, Tallman MS, Weisdorf DJ, Weisdorf DJ. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J Clin Oncol 2010; 28(23): 3730-3738.

IL-7 enhances survival of human CD56bright NK cells - Michaud A, Dardari R, Charrier E, Cordeiro P, Herblot S, Duval M. IL-7 enhances survival of human CD56bright NK cells. J Immunol 2010; 33(4): 382-390.

Umbilical cord blood T cells respond against the Melan-A/MART-1 tumor antigen and exhibit reduced alloreactivity as compared with adult blood-derived T cells - Merindol N, Grenier A, Caty M, Charrier E, Duval A, Duval M, Champagne MA, Soudeyns H. Umbilical cord blood T cells respond against the Melan-A/MART-1 tumor antigen and exhibit reduced alloreactivity as compared with adult blood-derived T cells. J Immunol 2010; 185(2): 856-866.

Influence of GST gene polymorphisms on busulfan pharmacokinetics in children - Ansari M, Lauzon-Joset JF, Vachon MF, Duval M, Théorêt Y, Champagne M, Krajinovic M. Influence of GST gene polymorphisms on busulfan pharmacokinetics in children. Bone Marrow Transplant 2010; 45(2): 261-267.

Allogeneic hematopoietic stem cell transplantation of patients with FA and high risk features using fludarabine without radiation - Baker J, Lewis V, Fernandez C, Duval M, Crooks B, Yuille K, Freedman M, Doyle J, Dror Y. Allogeneic hematopoietic stem cell transplantation of patients with FA and high risk features using fludarabine without radiation. Pediatr Blood Cancer 2009; 52(5): 683-685.

Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency - Qasim W, Cavazzana-Calvo M, Davies EG, Davis J, Duval M, Eames G, Farinha NJ, Filopovich A, Fischer A, Friedrich W, Gennery AR, Heilmann C, Landais P, Horwitz M, Porta F, Sedlacek P, Seger R, Slatter M, Teague L, Eapen M, Veys P. Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency. Pediatrics 2009; 123(3): 836-40. Erratum in: Pediatrics. 2009;123(5):1436.

Binding of thymoglobulin to natural killer cells leads to cell activation and interferon-gamma production - Dalle JH, Dardari R, Menezes J, Cordeiro P, Champagne M, Duval M. Binding of thymoglobulin to natural killer cells leads to cell activation and interferon-gamma production. Transplantation 2009; 87(4): 473-481.

Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313 - Pulsipher M, Boucher KM, Wall D, Frangoul H, Duval M, Goyal R, Shaw PJ, Haight A, Grimley M, Grupp SA, Kletzel M, Kadota Y. Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313. Blood 2009; 114(7): 1429-1436.

Mon enfant va recevoir une allogreffe de moelle, livre d'aide à la décision pour les familles - Duval M, Davous D, e. Mon enfant va recevoir une allogreffe de moelle, livre d'aide à la décision pour les familles. Espace Ethique, 2008; 87 pages.

Pediatric palliative care: a qualitative study of physicians' perspectives in a tertiary care university hospital - St-Laurent-Gagnon T, Carnevale F, Duval M. Pediatric palliative care: a qualitative study of physicians' perspectives in a tertiary care university hospital. J Palliat Care 2008; 24(1): 26-30.

Varicella-zoster virus disease is more frequent after cord blood than after bone marrow transplantation - Vandenbosch K, Ovetchkine P, Champagne M, Haddad E, Alexandrov L, Duval M. Varicella-zoster virus disease is more frequent after cord blood than after bone marrow transplantation. Biol Blood Marrow Tr 2008; 14(8): 867-871.

Determination of ketamine and norketamine in plasma by micro-liquid chromatography–mass spectrometry - Legrand T, Roy S, Monchaud C, Grondin C, Duval M, Jacqz-Aigrain E. Determination of ketamine and norketamine in plasma by micro-liquid chromatography–mass spectrometry . J Pharmaceut Biomed Anal 2008; 48(1): 171-176.

Length of cord blood unit cryopreservation does not impact hematopoietic engraftment - Jubert C, Wagner É, Bizier S, Vachon MF, Duval M, Champagne M. Length of cord blood unit cryopreservation does not impact hematopoietic engraftment. Transfusion 2008; 48(9): 2028-2030.

[Neonatal immunology and cord blood transplantation] - Charrier E, Dardari R, Michaud A, Cordeiro P, Duval M. [Neonatal immunology and cord blood transplantation]. Méd Sci (Paris) 2007; 23(11): 975-979.

Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease - Bernaudin F, Socie G, Kuentz M, Chevret S, Duval M, Bertrand Y, Vannier JP, Yakouben K, Thuret I, Bordigoni P, Fischer A, Lutz P, Stephan JL, Dhedin N, Plouvier E, Margueritte G, Bories D, Verlhac S, Esperou H, Coïc L, Vernant JP, Gluckman E, SFGM-TC. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 2007; 110(7): 2749-2756.

Toxic serum levels of tacrolimus after topical administration in an infant with severe cutaneous graft-versus-host disease - Prot-Labarthe S, Therrien R, Champagne M, Duval M, Joubert C. Toxic serum levels of tacrolimus after topical administration in an infant with severe cutaneous graft-versus-host disease. Bone Marrow Transplant 2007; 40(3): 295-296.

Multicenter randomized trial of chewing gum for preventing oral mucositis in children receiving chemotherapy - Gandemer V, Le Deley MC, Dollfus C, Auvrignon A, Bonnaure-Mallet M, Duval M, De Lumley L, Hartmann O, Mechinaud F, Sirvent N, Orbach D, Doireau V, Boutard P, Dalle JH, Reguerre Y, Pautard B, Aubier F, Schneider P, Suc A, Couillaut G, Schmitt C, Pain task force of the SFCE. Multicenter randomized trial of chewing gum for preventing oral mucositis in children receiving chemotherapy. J Pediatr Hematol Oncol 2007; 29(2): 86-94.

Le "Natural Killer", fer de lance des futures immunothérapies anti-tumorales (Potential role of Natural Killer cells in future anti-tumor immunotherapies) - Iannello A, Debbeche O, Samarani S, Sabbagh S, Duval M, Ahmad A. Le "Natural Killer", fer de lance des futures immunothérapies anti-tumorales (Potential role of Natural Killer cells in future anti-tumor immunotherapies). Médecine Sciences 2007; 23(5): 502-508.

Fluid balance of pediatric hematopoietic stem cell transplant recipients and intensive care unit admission - Benoit G, Phan V, Duval M, Champagne M, Litalien C, Mérouani A. Fluid balance of pediatric hematopoietic stem cell transplant recipients and intensive care unit admission. Pediatr Nephrol 2007; 22(3): 441-447.

Pregnancy after bone marrow transplantation in Fanconi anaemia - Dalle JH, Champagne M, Duval M. Pregnancy after bone marrow transplantation in Fanconi anaemia. Brit J Haematol 2007; 137(1): 76; author reply 76.

Complications of apheresis in children - Michon B, Moghrabi A, Winikoff R, Barrette S, Bernstein M, Champagne J, David M, Duval M, Hume HA, Robitaille N, Belisle A, Champagne M. Complications of apheresis in children. Transfusion 2007; 47: 1837-1842.

La transplantation de sang de cordon au Québec - Champagne M, Duval M, Wagner É. La transplantation de sang de cordon au Québec. Ann Biol Clin (Québec) 2006; 43: 3-10.

Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks - Wagner É, Duval M, Dalle JH, Morin H, Bizier S, Champagne J, Champagne M. Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks. Transfusion 2006; 46(7): 1190-1198.

Characterization of cord blood natural killer cells: implication for transplantation and neonatal infections - Dalle JH, Menezes J, Wagner É, Blagdon M, Champagne J, Champagne M, Duval M. Characterization of cord blood natural killer cells: implication for transplantation and neonatal infections. Pediatr Res 2005; 57(5 Pt 1): 649-655.

Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen - Brazzola P, Duval M, Fournet JC, Gauvin F, Dalle JH, Champagne J, Champagne M. Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen. Bone Marrow Transplant 2005; 36(12): 1103-1105.

Successful anti-CD20 antibody treatment of pemphigus foliaceus after unrelated cord blood transplantation - Herr AL, Hatami A, Kokta V, Dalle JH, Champagne J, Duval M. Successful anti-CD20 antibody treatment of pemphigus foliaceus after unrelated cord blood transplantation. Bone Marrow Transplant 2005; 35(4): 427-428.

Protein A column therapy for a patient refractory to platelet transfusions undergoing allogeneic hematopoietic stem cell transplantation - Larouche V, Hume HA, Moghrabi A, Duval M, Champagne J, Champagne M. Protein A column therapy for a patient refractory to platelet transfusions undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2005; 35(6): 623-624.

Second induction in pediatric patients with recurrent acute lymphoid leukemia using DFCI-ALL protocols - Dalle JH, Moghrabi A, Rousseau P, Leclerc JM, Barrette S, Bernstein M, Champagne J, David M, Demers J, Duval M, Hume HA, Meyer P, Champagne M. Second induction in pediatric patients with recurrent acute lymphoid leukemia using DFCI-ALL protocols. J Pediatr Hematol Oncol 2005; 27(2): 73-79.

Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow - Dalle JH, Duval M, Moghrabi A, Wagner É, Vachon MF, Barrette S, Bernstein M, Champagne J, David M, Demers J, Rousseau P, Winikoff R, Champagne M. Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow. Bone Marrow Transplant 2004; 33(6): 605-611.

Autres symptômes: une revue générale des données scientifiquement validées - Duval M, Faure C, Lortie A, Pasquasy V, Lapierre J-G. Autres symptômes: une revue générale des données scientifiquement validées. Dans: Humbert N (ed). Les soins palliatifs pédiatriques. Collection Intervenir. Montréal, Qc. Éditions de l'Hôpital Sainte-Justine, 2004; 199-259.

Urgence en greffe hématopoïétique - Duval M. Urgence en greffe hématopoïétique. Dans: Huault G, Labrune B (eds). Pédiatrie d'Urgence. Paris. ESTEM, 2004; 797-801.

Soins palliatifs - Duval M, Wood C. Soins palliatifs. Dans: Huault G, Labrune B (eds). Pédiatrie d'Urgence. Paris. ESTEM, 2004; 1299-1300.

Prise en charge de la douleur - Wood C, Duval M, Teisseyre L, de Crouy AC. Prise en charge de la douleur. Dans: Huault G, Labrune B (eds). Pédiatrie d'Urgence. Paris. ESTEM, 2004; 1249-1255.

Successful pregnancies after bone marrow transplantation for Fanconi anemia - Dalle JH, Huot C, Duval M, Rousseau P, Francoeur D, Champagne J, Vachon MF, Champagne M. Successful pregnancies after bone marrow transplantation for Fanconi anemia. Bone Marrow Transplant 2004; 34(12): 1099-1100.

Is routine chest radiography necessary for the initial evaluation of fever in neutropenic children with cancer? - Renoult E, Buteau C, Turgeon N, Moghrabi A, Duval M, Tapiero B. Is routine chest radiography necessary for the initial evaluation of fever in neutropenic children with cancer?. Pediatr Blood Cancer 2004; 43(3): 224-228.

Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Paris-Robert Debre experience - Acquaviva C, Duval M, Mirebeau D, Bertin R, Cave H. Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Paris-Robert Debre experience. Leukemia 2003; 17(1): 241-246.

Common genomic HLA haplotypes contributing to successful donor search in unrelated hematopoietic transplantation - Pédron B, Duval M, Elbou OM, Moskwa M, Jambou M, Vilmer E, Sterkers G. Common genomic HLA haplotypes contributing to successful donor search in unrelated hematopoietic transplantation. Bone Marrow Transplant 2003; 31(6): 423-427.

Intravenous busulfan for allogeneic hematopoietic stem cell transplantation in infants: clinical and pharmacokinetic results - Dalle JH, Wall D, Théorêt Y, Duval M, Shaw L, Larocque D, Taylor C, Gardiner J, Vachon MF, Champagne M. Intravenous busulfan for allogeneic hematopoietic stem cell transplantation in infants: clinical and pharmacokinetic results. Bone Marrow Transplant 2003; 32(7): 647-651.

Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial - Duval M, Suciu S, Ferster A, Rialland X, Nelken B, Lutz P, Benoit Y, Robert A, Manel AM, Vilmer E, Otten J, Philippe N, for the European Organization for Research and Treatment of Cancer-Children's Leukemia Group. Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial. Blood 2002; 99(8): 2734-2739.

Immune reconstitution after haematopoietic transplantation with two different dosages of pre-graft antithymocyte globulin - Duval M, Pédron B, Rohrlich P, Legrand F, Faye A, Lescoeur B, Bensaid P, Larchee R, Sterkers G, Vilmer E. Immune reconstitution after haematopoietic transplantation with two different dosages of pre-graft antithymocyte globulin. Bone Marrow Transplant 2002; 30(7): 421-426.

Traitement des symptômes non douloureux chez l'enfant en fin de vie - Duval M, Wood C. Traitement des symptômes non douloureux chez l'enfant en fin de vie. Arch Pediatr 2002; 9(11): 1173-1178.

Unrelated bone marrow transplantation for leukocyte adhesion deficiency - Farinha NJ, Duval M, Wagner É, Champagne J, Lapointe N, Barrette S, Tapiero B, Busque L, Champagne M. Unrelated bone marrow transplantation for leukocyte adhesion deficiency. Bone Marrow Transplant 2002; 30(12): 979-981.

Cerebellar herniation after intrathecal chemotherapy including cytosine arabinoside in a boy with T acute lymphoblastic leukemia - Legrand F, Dorgeret S, Saizou C, Duval M, Vilmer E. Cerebellar herniation after intrathecal chemotherapy including cytosine arabinoside in a boy with T acute lymphoblastic leukemia. Leukemia 2002; 16(12): 2454-2455.

À propos de cette page

Créée le 22 juillet 2014
Signaler ou faire une remarque

Chaque dollar compte !

Merci de votre générosité.

Ce sont les donateurs comme vous qui nous permettent d’accélérer la recherche, de guérir, à chaque année, plus d’enfants et continuer d’offrir un des meilleurs niveaux de santé au monde.

Il est également possible de donner par la poste ou de donner par téléphone au numéro sans frais

1-888-235-DONS (3667)

Nous contacter

514 345-4931

Légal

© 2006-2014 Centre de recherche du CHU Sainte-Justine.
Tous droits réservés.
Avis légaux  Confidentialité  Sécurité

Avertissement

Les informations contenues dans le site « CHU Sainte-Justine » ne doivent pas être utilisées comme un substitut aux conseils d’un médecin dûment qualifié et autorisé ou d’un autre professionnel de la santé. Les informations fournies ici le sont à des fins exclusivement éducatives et informatives.

Consultez votre médecin si vous croyez être malade ou composez le 911 pour toute urgence médicale.

CHU Sainte-Justine